{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:45:44Z","timestamp":1766155544181,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.clcc.2023.03.003","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T11:55:56Z","timestamp":1680004556000},"page":"267-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anti-VEGF Therapy Possibly Extends Survival in Patients With Colorectal Brain Metastasis by Protecting Patients From Neurologic Disability"],"prefix":"10.1016","volume":"22","author":[{"given":"Chih-Wen","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao-Shen","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Shone","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeng-Kai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shung-Haur","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huann-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ching","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Tzu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Chi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Hsin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Chieh","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hou-Hsuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Zu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yee","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Wei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clcc.2023.03.003_bib0001","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jfma.2019.08.023","article-title":"Cancers in Taiwan: practical insight from epidemiology, treatments, biomarkers, and cost","volume":"119","author":"Kuo","year":"2020","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"10.1016\/j.clcc.2023.03.003_bib0002","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/cancers13040900","article-title":"Brain metastases from colorectal cancer: a systematic review of the literature and meta-analysis to establish a guideline for daily treatment","volume":"13","author":"M\u00fcller","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.clcc.2023.03.003_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7407190","article-title":"Mechanisms of metastasis in colorectal cancer and metastatic organotropism: hematogenous versus peritoneal spread","volume":"2019","author":"Pretzsch","year":"2019","journal-title":"J Oncol"},{"issue":"10","key":"10.1016\/j.clcc.2023.03.003_bib0004","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/cncr.10541","article-title":"Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma","volume":"94","author":"Schouten","year":"2002","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clcc.2023.03.003_bib0005","first-page":"108","article-title":"Changing patterns of bone and brain metastases in patients with colorectal cancer","volume":"5","author":"Sundermeyer","year":"2005","journal-title":"Clin Colorectal Cancer"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0006","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12885-016-2290-5","article-title":"Systematic review: brain metastases from colorectal cancer\u2014incidence and patient characteristics","volume":"16","author":"Christensen","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0007","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11060-010-0214-9","article-title":"Brain metastases from colorectal carcinoma: prognostic factors and outcome","volume":"101","author":"Jung","year":"2011","journal-title":"J Neurooncol"},{"issue":"11","key":"10.1016\/j.clcc.2023.03.003_bib0008","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10151-017-1707-8","article-title":"A systematic review to assess the management of patients with cerebral metastases secondary to colorectal cancer","volume":"21","author":"Silva","year":"2017","journal-title":"Tech Coloproctol"},{"issue":"10","key":"10.1016\/j.clcc.2023.03.003_bib0009","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jocn.2012.12.020","article-title":"Clinical outcome with gamma-knife surgery or surgery for brain metastases from colorectal cancer","volume":"20","author":"Kim","year":"2013","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-011-0203-y","article-title":"Epidemiology of brain metastases","volume":"14","author":"Nayak","year":"2012","journal-title":"Curr Oncol Rep"},{"issue":"14","key":"10.1016\/j.clcc.2023.03.003_bib0011","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System","volume":"22","author":"Barnholtz-Sloan","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0012","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1186\/s12885-019-5973-x","article-title":"Prognostic factors of brain metastases from colorectal cancer","volume":"19","author":"Imaizumi","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2023.03.003_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-61354-y","article-title":"Prognostic factors for survival in colorectal cancer patients with brain metastases undergoing whole brain radiotherapy: multicenter retrospective study","volume":"10","author":"Koo","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clcc.2023.03.003_bib0014","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.2147\/CMAR.S180173","article-title":"Brain metastases in newly diagnosed colorectal cancer: a population-based study","volume":"10","author":"Yang","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"23","key":"10.1016\/j.clcc.2023.03.003_bib0015","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clcc.2023.03.003_bib0016","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1200\/JCO.2001.19.3.843","article-title":"Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer","volume":"19","author":"Gordon","year":"2001","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0017","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11060-017-2693-4","article-title":"Bevacizumab and risk of intracranial hemorrhage in patients with brain metastases: a meta-analysis","volume":"137","author":"Yang","year":"2018","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0018","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1158\/1078-0432.CCR-09-2439","article-title":"Bevacizumab safety in patients with central nervous system metastases","volume":"16","author":"Besse","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"31","key":"10.1016\/j.clcc.2023.03.003_bib0019","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1200\/JCO.2009.22.0616","article-title":"Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases","volume":"27","author":"Socinski","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0020","first-page":"vdaa038","article-title":"Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases","volume":"2","author":"Berghoff","year":"2020","journal-title":"Neurooncol Adv"},{"issue":"2","key":"10.1016\/j.clcc.2023.03.003_bib0021","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000360930","article-title":"Alleviation of brain edema and restoration of functional independence by bevacizumab in brain-metastatic breast cancer: a case report","volume":"9","author":"Berghoff","year":"2014","journal-title":"Breast Care (Basel)"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0022","first-page":"65","article-title":"Bevacizumab in the treatment of a patient with metastatic colorectal carcinoma with brain metastases","volume":"7","author":"Bhaskara","year":"2008","journal-title":"Clin Colorectal Cancer"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0023","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12029-015-9795-z","article-title":"Bevacizumab in combination with chemotherapy for colorectal brain metastasis","volume":"47","author":"Finkelmeier","year":"2016","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0024","doi-asserted-by":"crossref","first-page":"55","DOI":"10.21037\/jgo.2016.12.11","article-title":"Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experience","volume":"8","author":"Fountzilas","year":"2017","journal-title":"J Gastrointest Oncol"},{"issue":"9","key":"10.1016\/j.clcc.2023.03.003_bib0025","first-page":"4061","article-title":"Bevacizumab as front-line treatment of brain metastases from solid tumors: a case series","volume":"33","author":"Zustovich","year":"2013","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.clcc.2023.03.003_bib0026","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","article-title":"Response assessment criteria for brain metastases: proposal from the RANO group","volume":"16","author":"Lin","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0027","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1038\/s41467-019-10987-3","article-title":"Genomic signatures reveal DNA damage response deficiency in colorectal cancer brain metastases","volume":"10","author":"Sun","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.clcc.2023.03.003_bib0028","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/nprot.2009.97","article-title":"Mapping Identifiers for the Integration of Genomic Datasets with the R\/Bioconductor package biomaRt","volume":"4","author":"Durinck","year":"2009","journal-title":"Nat Protoc"},{"issue":"5","key":"10.1016\/j.clcc.2023.03.003_bib0029","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3747\/co.19.1048","article-title":"Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution","volume":"19","author":"Damiens","year":"2012","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cncr.23531","article-title":"Multidisciplinary management of colorectal brain metastases: a retrospective study","volume":"113","author":"Kruser","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clcc.2023.03.003_bib0031","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10147-019-01552-5","article-title":"Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases","volume":"25","author":"Wang","year":"2020","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0032","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13058-020-01372-w","article-title":"Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases","volume":"22","author":"Leone","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"8","key":"10.1016\/j.clcc.2023.03.003_bib0033","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1158\/1078-0432.CCR-14-2082","article-title":"Bevacizumab in patients with nonsquamous non-small cell lung cancer and asymptomatic, untreated brain metastases (BRAIN): a nonrandomized, phase II study","volume":"21","author":"Besse","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2023.03.003_bib0034","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/OTT.S36515","article-title":"Bevacizumab in the treatment of five patients with breast cancer and brain metastases: Japan Breast Cancer Research Network-07 trial","volume":"5","author":"Yamamoto","year":"2012","journal-title":"Onco Targets Ther"},{"issue":"4","key":"10.1016\/j.clcc.2023.03.003_bib0035","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/annonc\/mdv012","article-title":"Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial","volume":"26","author":"Masi","year":"2015","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.clcc.2023.03.003_bib0036","doi-asserted-by":"crossref","first-page":"15784","DOI":"10.3390\/ijms131215784","article-title":"Brain metastases from colorectal cancer: microenvironment and molecular mechanisms","volume":"13","author":"Zang","year":"2012","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.clcc.2023.03.003_bib0037","first-page":"100","article-title":"Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines","volume":"8","author":"Mongan","year":"2009","journal-title":"Clin Colorectal Cancer"},{"issue":"1","key":"10.1016\/j.clcc.2023.03.003_bib0038","first-page":"vdaa041","article-title":"Epidemiology of synchronous brain metastases","volume":"2","author":"Singh","year":"2020","journal-title":"Neurooncol Adv"},{"issue":"6","key":"10.1016\/j.clcc.2023.03.003_bib0039","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1590\/S1516-31801997000600006","article-title":"CEA as a prognostic index in colorectal cancer","volume":"115","author":"Forones","year":"1997","journal-title":"Sao Paulo Med J"},{"issue":"9","key":"10.1016\/j.clcc.2023.03.003_bib0040","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/archsurg.138.9.962","article-title":"Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer","volume":"138","author":"Dixon","year":"2003","journal-title":"Arch Surg"},{"key":"10.1016\/j.clcc.2023.03.003_bib0041","article-title":"Survival outcome of surgical resection vs. radiotherapy in brain metastasis from colorectal cancer: a meta-analysis","volume":"9","author":"Chang","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"10.1016\/j.clcc.2023.03.003_bib0042","first-page":"711","article-title":"Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases","volume":"12","author":"McPherson","year":"2010","journal-title":"Neurooncology"},{"issue":"suppl 3","key":"10.1016\/j.clcc.2023.03.003_bib0043","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1200\/JCO.2021.39.3_suppl.40","article-title":"The pattern of brain metastasis in colorectal cancer: efficacy of metastasectomy, chemotherapy","volume":"39","author":"Goksu","year":"2021","journal-title":"J Clin Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002823000348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002823000348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:08:44Z","timestamp":1761520124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002823000348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1533002823000348"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2023.03.003","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-VEGF Therapy Possibly Extends Survival in Patients With Colorectal Brain Metastasis by Protecting Patients From Neurologic Disability","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2023.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}